R.H. Bluestein & Co’s DaVita DVA Stock Holding History

R.H. Bluestein & Co’s Portfolio DVA Stock Details DVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-5,000	Closed	-$340K	–	314
2017 Q1	$340K	Hold	5,000	–	–	0.02%	218
2016 Q4	$321K	Hold	5,000	–	–	0.02%	202
2016 Q3	$330K	Hold	5,000	–	–	0.02%	178
2016 Q2	$387K	Hold	5,000	–	–	0.03%	135
2016 Q1	$367K	Hold	5,000	–	–	0.03%	163
2015 Q4	$349K	Hold	5,000	–	–	0.02%	182
2015 Q3	$362K	Hold	5,000	–	–	0.03%	183
2015 Q2	$397K	Hold	5,000	–	–	0.02%	210
2015 Q1	$406K	Sell	5,000 -5,650	-53%	-$434K	0.02%	197
2014 Q4	$807K	Buy	10,650 +4,250	+66%	+$320K	0.05%	114
2014 Q3	$468K	Buy	+6,400	New	+$469K	0.03%	204
2013 Q4	–	Sell	-4,400	Closed	-$250K	–	362
2013 Q3	$250K	Buy	+4,400	New	+$252K	0.02%	287

Other funds holding DVA

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

R.H. Bluestein & Co's DVA Position: Q2 2017 in Review

R.H. Bluestein & Co sold out of DaVita (DVA) in Q2 2017, closing a stake of 5,000 shares — an estimated $340K sold.

R.H. Bluestein & Co first reported a position in DVA in Q3 2013 and held it in 12 quarters. The position peaked at $807K in Q4 2014. 477 funds tracked by Wall St. Rank hold DVA as of Q2 2017.

R.H. Bluestein & Co reported no remaining DaVita position as of Q2 2017 after selling out during the quarter.
R.H. Bluestein & Co sold 5,000 DaVita shares in Q2 2017, an estimated $340K.
R.H. Bluestein & Co first reported a position in DaVita in Q3 2013 and held it in 12 quarters.
R.H. Bluestein & Co's DaVita position peaked at $807K in Q4 2014.
477 funds tracked by Wall St. Rank held DaVita as of Q2 2017.

Based on R.H. Bluestein & Co's 13F filing for Q2 2017, filed 11 Aug 2017.